Top 50 Medical Device Startup Investors in Oceania (July 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Icehouse Ventures
VC Fund
|
9 | New Zealand, United States, United Kingdom | Seed, Series A | Software, SaaS, Information Technology | $612k–$16M |
|
Artesian VC
VC Fund
|
9 | Australia, United States, Hong Kong | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Health Care | $40k–$15M |
|
Brandon Capital
VC Fund
|
8 | Australia, United Kingdom, United States | Series A, Seed, Series B | Biotechnology, Health Care, Medical | $673k–$115M |
|
Pacific Channel
VC Fund
|
8 | New Zealand, Australia, Canada | Seed, Venture - Series Unknown, Series A | Manufacturing, Medical Device, Health Care | $938k–$15M |
|
New Zealand Growth Capital Partners
VC Fund
|
7 | New Zealand, United States, Australia | Seed, Venture - Series Unknown, Series A | Software, Medical Device, Manufacturing | $608k–$17M |
|
Medical Research Commercialisation Fund (MRCF)
VC Fund
|
6 | Australia, United States, United Kingdom | Series A, Seed, Series B | Biotechnology, Health Care, Medical | $1.3M–$16M |
|
Movac
VC Fund
|
6 | New Zealand, United States, Australia | Seed, Series A | Software, SaaS, E-Commerce | $795k–$18M |
|
Cure Kids Ventures
VC Fund
|
6 | New Zealand | Seed, Pre-Seed, Series A | Medical Device, Health Care, Manufacturing | $1.7M–$4.3M |
|
Uniservices
VC Fund
|
6 | New Zealand, United States | Seed, Pre-Seed, Venture - Series Unknown | Health Care, Medical Device, Manufacturing | $1M–$4M |
|
Breakthrough Victoria
VC Fund
|
5 | Australia, United States, Philippines | Seed, Series A, Venture - Series Unknown | Health Care, Manufacturing, Biotechnology | $600k–$30M |
|
Uniseed
VC Fund
|
5 | Australia, United States, United Kingdom | Series A, Seed, Series B | Biotechnology, Health Care, Manufacturing | $471k–$22M |
|
Enterprise Angels
VC Fund
|
4 | New Zealand, United States, United Kingdom | Seed, Angel | Software, Information Technology, Health Care | $153k–$4.3M |
|
K1W1
VC Fund
|
4 | New Zealand, United States | Seed, Series A | Software, Artificial Intelligence, SaaS | $419k–$18M |
|
Global from Day One
VC Fund
|
4 | New Zealand, United States, China | Seed, Series A | Software, SaaS, Medical Device | $612k–$18M |
|
Everywhere Ventures
VC Fund
|
4 | United States, Australia, India | Pre-Seed, Seed, Series A | Software, Health Care, FinTech | $550k–$60M |
|
Flying Kiwi Angels
VC Fund
|
4 | New Zealand, United States | Seed, Angel, Pre-Seed | Software, Medical Device, Information Technology | $334k–$4.3M |
|
Sydney Angels
VC Fund
|
4 | Australia, United States | Seed, Angel, Pre-Seed | Software, SaaS, Health Care | $120k–$1.5M |
|
Melbourne Angels
VC Fund
|
4 | Australia, United States, New Zealand | Angel, Seed | Biotechnology, Information Technology, Energy | $34k–$1.3M |
|
Brisbane Angels
VC Fund
|
3 | Australia, United States, New Zealand | Seed, Pre-Seed, Angel | Software, Information Technology, Artificial Intelligence | $120k–$1.5M |
|
IP Group
VC Fund
|
3 | United Kingdom, United States, Australia | Seed, Series A | Health Care, Biotechnology, Therapeutics | $393k–$23M |
|
Booster
VC Fund
|
3 | New Zealand, United States | Seed, Venture - Series Unknown | Robotics, Biotechnology, Medical Device | $158k–$6.1M |
|
Significant Ventures
VC Fund
|
3 | Australia | Seed, Series A | Manufacturing, Software, Health Care | $67k–$8.2M |
|
GD1 (Global From Day One)
VC Fund
|
3 | New Zealand, United States, China | Seed, Series A, Pre-Seed | Software, Information Technology, SaaS | $600k–$16M |
|
Nuance Capital
VC Fund
|
3 | New Zealand, United States | Seed, Series A, Convertible Note | Software, Manufacturing, Medical Device | $1.7M–$10M |
|
b2venture
VC Fund
|
3 | Germany, Switzerland, United Kingdom | Series A, Seed, Series B | Software, Health Care, Information Technology | $1.3M–$52M |
|
Fund WA
VC Fund
|
2 | Australia | Seed, Series A | Medical, Health Care, Manufacturing | |
|
Sirius Capital
VC Fund
|
2 | China, Australia | Series A, Seed, Angel | Artificial Intelligence, Robotics, Video | $1.4M–$50M |
|
Anova Capital
VC Fund
|
2 | China, Australia | Series A, Seed | Education, Rental, Travel | $1.4M–$4.6M |
|
Development Bank of Wales
VC Fund
|
2 | United Kingdom, Australia, United States | Seed, Debt Financing | Software, Health Care, Biotechnology | $18k–$4.1M |
|
CoAct Capital
VC Fund
|
2 | Australia, New Zealand | Series A, Seed, Series B | Software, Information Technology, SaaS | $4.4M–$14M |
|
SFC Capital
VC Fund
|
2 | United Kingdom, United States, Canada | Pre-Seed, Seed | Artificial Intelligence, Software, Information Technology | $127k–$2M |
|
Matū Group
VC Fund
|
2 | New Zealand, United States | Seed, Pre-Seed, Venture - Series Unknown | Biotechnology, Health Care, Robotics | |
|
Global Health Investment Fund (GHIF)
VC Fund
|
2 | United States, India, Austria | Series B, Series C | Health Care, Biotechnology, Medical Device | $4.5M–$18M |
|
Allan Moss
Angel
|
2 | Australia, United States, The Netherlands | Series A, Seed | Health Care, Medical Device, Biotechnology | $2.4M–$8.8M |
|
Flying Kiwis
VC Fund
|
2 | New Zealand | Seed | SaaS, 3D Technology, Medical Device | $5M–$5M |
|
Regal Funds Management
VC Fund
|
2 | Australia, United States, United Kingdom | Convertible Note, Series B | Software, Financial Services, FinTech | $1.7M–$26M |
|
Punakaiki Fund
VC Fund
|
2 | New Zealand, United States | Seed, Series A | Software, SaaS, Information Technology | $355k–$12M |
|
South Australian Venture Capital Fund
VC Fund
|
2 | Australia | Seed, Series B, Series A | Health Care, Biotechnology, Internet of Things | $1M–$24M |
|
Left Lane Capital
VC Fund
|
2 | United States, Germany, Canada | Series A, Series B, Seed | FinTech, Financial Services, Software | $2.5M–$100M |
|
Bridgewest Ventures
VC Fund
|
2 | New Zealand | Seed | Manufacturing, Medical Device, Eyewear | $2.5M–$2.8M |
|
Renew Pharmaceuticals
VC Fund
|
2 | Australia | Series A, Series B | Health Care, Biotechnology, Medical Device | $5.6M–$6M |
|
Clare Ventures
VC Fund
|
2 | Australia | Series A | Health Care, Medical Device | $1.2M–$4.7M |
|
Uniseed Ventures
VC Fund
|
2 | Australia, United States, United Kingdom | Series A, Seed | Biotechnology, Health Care, Manufacturing | $381k–$16M |
|
CP Ventures
VC Fund
|
1 | Australia, United States, India | Seed, Pre-Seed | Software, Artificial Intelligence, Machine Learning | $350k–$3.9M |
|
Quayside Holdings
VC Fund
|
1 | New Zealand | Seed, Series B | Sensor, FinTech, Hardware | |
|
Horizons Ventures
VC Fund
|
1 | United States, United Kingdom, Canada | Series A, Series B, Seed | Biotechnology, Software, Artificial Intelligence | $1M–$110M |
|
Ramsay Health Care
VC Fund
|
1 | Australia | Series A | Medical, Health Care, Medical Device | |
|
OneVentures
VC Fund
|
1 | Australia, United States, Israel | Series A, Debt Financing | Software, Health Care, Biotechnology | $1M–$20M |
|
HealthCare Ventures
VC Fund
|
1 | United States, Australia, United Kingdom | Series B, Series A, Series C | Biotechnology, Health Care, Pharmaceutical | $4.4M–$50M |
|
Future of Healthcare Fund - Australian Unity
VC Fund
|
1 | Australia | Series A | Health Care, Medical Device | |
| Access all 50 investors in Oceania Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Icehouse Ventures is an early-stage venture capital firm. We exist to back the world's bravest Kiwi founders, launching global companies from New Zealand.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Series A
- Geography: New Zealand, United States, United Kingdom
Investor stats
- Total investments: 213
- Round size: Seed $612k–$5M; Series A $2.2M–$16M
- Lead/follow: 16% lead, 84% follow
- Last fund: Likely still investing — raised $69M in 2021
Portfolio highlights
- Hnry — Hnry automatically pays and files all taxes for contractors, freelancers, and sole traders, so they never have to think about tax again.
- Vessev — Vessev is a maritime trasportantion company that offers hydrofoiling electric vessels for travelling through water.
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Australia, United States, Hong Kong
Investor stats
- Total investments: 246
- Round size: Seed $135k–$4.6M; Pre-Seed $40k–$1.5M; Series A $2.3M–$15M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Vaulta — Discover Vaulta's high-performance batteries for sustainable energy solutions. Revolutionising power with easy installation, maintenance, and recycling. Join the Australian-made energy revolution today!
- Andromeda Robotics — At Andromeda, our personalised robot companions are helping Australian aged care teams bring joy and connection to residents to improve wellbeing.
- Infiction labs — SPARC 1.2 is a solar panel robotic cleaning system designed and developed by Infiction Labs Pvt Ltd for commercial solar plants.
Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Series B
- Geography: Australia, United Kingdom, United States
Investor stats
- Total investments: 69
- Round size: Seed $673k–$6.7M; Series A $4.9M–$115M; Series B $6.4M–$68M
- Lead/follow: 28% lead, 72% follow
- Last fund: May invest from a new fund soon — raised $210M in 2019
Portfolio highlights
- Myricx Bio — Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
- OncoRes Medical — OncoRes Medical develops an imaging technology to provide intraoperative information available to surgeons to assist with the identification of tumor and healthy tissue.OncoRes Medical is an early-stage medical device company located in Perth, Western Australia and is developing the patent-protected technology in collaboration with leadingresearchers at the University of Western Australia and the Harry Perkins Institute of Medical Research and breast cancer surgeons at the Western Australian public health system.With funding provided by the Medical Research Commercialisation Fund (MRCF), OncoRes Medical aims to develop the technology for use in clinical applications that require the real-time assessment of tissue microstructure.
- NRG Therapeutics — energizing drug discovery in neurodegenerative diseases.
Investing in great people solving hard problems to create a better future.
Show more...Investment focus
- Industry: Manufacturing, Medical Device, Health Care
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: New Zealand, Australia, Canada
Investor stats
- Total investments: 45
- Round size: Seed $938k–$5M; Series A $6M–$15M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- Tectonus — Revolutionary self-centring seismic connections that protect structures in earthquake sequences.
- Regen —
- Androgenix —
The New Zealand Growth Capital Partners (formerly New Zealand Venture Investment Fund) was established to support early-stage technology companies and to stimulate private investment into this space.
Show more...Investment focus
- Industry: Software, Medical Device, Manufacturing
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: New Zealand, United States, Australia
Investor stats
- Total investments: 48
- Round size: Seed $830k–$4.9M; Series A $6.2M–$17M; Venture - Series Unknown $608k–$6.1M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
- Scentian Bio — Scentian Bio operates as a platform that provides ultimate sensing solution.
- Quantifi Photonics — Quantifi Photonics is a critical supplier of photonics test and measurement instruments to the world's leading photonics manufacturers, universities and research organizations.
Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Seed, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 26
- Round size: Series A $1.3M–$13M; Series B $6.4M–$16M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- MycRx — MecRx is a drug development company that works on new treatments for cancer and novel mechanism of action antibiotics. Using proprietary “hit identification” technology, MecRx is developing inhibitors of cMyc, a protein that is deregulated in over 50% of all human cancers. MecRx draws on the expertise of the Peter MacCallum Cancer Centre and CSIROand is headquartered in Melbourne, Australia.MecRx was founded in 2013 by an ex-pharma/biotech team. MecRx is run as a virtual company based in Melbourne, Australia and its shareholders and service providers include the Peter MacCallum Cancer Institute and CSIRO. The company secured $5m Series A investment from the MRCF (www.mrcf.com.au) and CSIRO in 2015.
- Currus Biologics — Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
- Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
Movac is New Zealand's most experienced technology investor and is deeply integrated into the Kiwi tech sector. We've been actively investing since 1998.
Show more...Investment focus
- Industry: Software, SaaS, E-Commerce
- Stage:Seed, Series A
- Geography: New Zealand, United States, Australia
Investor stats
- Total investments: 61
- Round size: Seed $1.5M–$4.4M; Series A $795k–$18M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely still investing — raised $125M in 2022
Portfolio highlights
- Hnry — Hnry automatically pays and files all taxes for contractors, freelancers, and sole traders, so they never have to think about tax again.
- LawVu — Our all-in-one connected platform enables your legal team to manage all legal matters, contracts, spend and legal operations. Book your free demo now.
- 1Above — 1Above is designed with Vitamins, Electrolytes and Super Antioxidant to help you recover faster on Travel, Work, Party occasions. Well known to help combat jet lag since 2010.
Investing in innovation for a healthy childhood Investing in innovation for a healthy childhood About Cure Kids Ventures Cure Kids Ventures is a seed and early stage investment fund that invests in the commercialisation of innovations in products and services with a potential to
Show more...Investment focus
- Industry: Medical Device, Health Care, Manufacturing
- Stage:Seed, Pre-Seed, Series A
- Geography: New Zealand
Investor stats
- Total investments: 9
- Round size: Seed $1.7M–$4.3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- chnnl — Optimise your employee wellbeing strategy with chnnl. Centralised resource management, track psychosocial risks and team psychological wellbeing measurement.
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
- ISpy Nits — ISpy Nits manufacturer develops a biofluorescent powder for treating lice and nits. The company's product kit includes lotion and a non-toxic glow powder that binds to the egg sheath to intensify the effect. As the chemicals interact with bioluminescent proteins, they emit light that is visible to the human eye, identifying lice and their eggsand removing them.
Auckland University's commercialisation arm
Show more...Investment focus
- Industry: Health Care, Medical Device, Manufacturing
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: New Zealand, United States
Investor stats
- Total investments: 19
- Round size: Seed $1M–$2.8M; Venture - Series Unknown $3.2M–$4M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- RosterLab — RosterLab goal is to automate every part of the rostering process for healthcare.
- Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
- Zenno Astronautics — Zenno Astronautics hardware and software products ensure satellite missions are effectively managed, guaranteeing maximum economic returns and responsible use of space.
The Breakthrough Victoria Fund is a $2 billion investment by the Victorian Government to drive investment in research and innovation.
Show more...Investment focus
- Industry: Health Care, Manufacturing, Biotechnology
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Australia, United States, Philippines
Investor stats
- Total investments: 52
- Round size: Seed $708k–$6.8M; Series A $1.7M–$30M; Venture - Series Unknown $600k–$30M
- Lead/follow: 56% lead, 44% follow
Portfolio highlights
- DeepDerm — DeepDerm is developing AI-enabled cameras that detect skin cancer without the need for painful biopsies.
- AlleSense — AlleSense develops a label-free optical imaging technology designed to enhance disease diagnosis by manipulating light-tissue interactions at the nanoscale. It's Mission is to Reimagining the standard microscope slide to make digital pathology faster, more accurate, and accessible without complex chemical staining.
- Deftbiotech — Deftbiotech is a biotech startup developing peptide-based antifungal treatments for nail and skin infections.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Series A, Seed, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 86
- Round size: Seed $600k–$3.5M; Series A $1.6M–$16M; Series B $471k–$22M
- Lead/follow: 22% lead, 78% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- DeteQt — Semiconductor chip-based quantum magnetic field sensors using diamond - navigation, mining, medical imaging
- Plasmaleap —
- Analog Quantum Circuits — Analog Quantum Circuits develops analog components for solid-state quantum computers.
Connecting startup business owners with angel investors to raise capital . Access a network of expertise and investment opportunities.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Angel
- Geography: New Zealand, United States, United Kingdom
Investor stats
- Total investments: 120
- Round size: Seed $153k–$4.3M; Angel $229k–$651k
- Lead/follow: 8% lead, 92% follow
- Last fund: May invest from a new fund soon — raised $12M in 2019
Portfolio highlights
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
- Scanabull — Scanabull is a 3D vision to measure cattle live weight quickly and accurately, reducing handling stress and giving farmers, agents, and processors clear, real‑time weight data. It makes weighing easy, analysis simple, and sharing seamless for everyone who relies on live weight or carcass weight decisions.
- Kai's Education — Kai's Education is an innovative force in the EdTech sector, pioneering the integration of coding, STEM, and robotics into engaging learning experiences for children. Based in Auckland, New Zealand, our mission is to ignite young minds through our award-winning educational products, including the all-in-one STEAM toolbox, Kai's Clan, andthe hybrid robot, KaiBot.Our flagship product, Kai's Clan, breaks new ground by allowing children aged seven to fifteen to learn to code with state-of-the-art technologies such as AR, VR, AI, IoT, Tinkercad, and Minecraft. KaiBot, designed for hands-on learning, uses screen-free coding cards to instill the fundamentals of coding, providing immediate feedback to enhance learning.Complemented by the Kainundrum Lite app, Kai's Education facilitates a seamless transition from tactile to advanced text-based coding, nurturing problem-solving skills and creativity. Recipient of the Smart AI Toy Award and the Common Sense Top Pick for Learning Award, Kai's Education is dedicated to equipping the next generation with the skills for tomorrow's challenges. We're not just teaching coding; we're inspiring creators.
K1W1 provides startups and businesses in New Zealand with early and later-stage venture investments.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A
- Geography: New Zealand, United States
Investor stats
- Total investments: 100
- Round size: Seed $550k–$4.1M; Series A $419k–$18M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Evnex — NZ manufactured and installed EV chargers for homes and businesses. Starting at $2,295 inc for a charger and full install - Electric vehicle charging simplified.
- Groov —
- Astrix Astronautics — Inflatable, rigidising deployment enables low-cost spacecraft solar arrays, high gain antennas, powering earth with solar energy from space, and more.
GD1 is a Venture Capital firm that invests with high conviction in exciting technology companies originating from New Zealand. Our team is passionate about creating and growing global businesses, and our goal is to transform NZ made into the next generation of globally disruptive tech solutions.
Show more...Investment focus
- Industry: Software, SaaS, Medical Device
- Stage:Seed, Series A
- Geography: New Zealand, United States, China
Investor stats
- Total investments: 29
- Round size: Seed $612k–$5M; Series A $1.2M–$18M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $90M in 2021
Portfolio highlights
- eVouch — eVouch is the most powerful marketing tool we've used to build an organic community. We've experienced elevated brand trust while reaching an audience we never thought possible. Using customers to market to their friends is simply genius.
- Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
- Flowingly — Unlock Team Productivity. Streamline Approvals. Increase Compliance. Easy To Use, No-Code Process Mapping & Workflow Automation Platform.
Everywhere Ventures is a global pre-seed venture capital fund for founders, by founders. Click to read Everywhere VC, by Everywhere Ventures, a Substack publication with tens of thousands of subscribers.
Show more...Investment focus
- Industry: Software, Health Care, FinTech
- Stage:Pre-Seed, Seed, Series A
- Geography: United States, Australia, India
Investor stats
- Total investments: 714
- Round size: Seed $1.5M–$7.2M; Pre-Seed $550k–$2.7M; Series A $10M–$60M
- Lead/follow: 2% lead, 98% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Donna — Meet Donna, the AI assistant built for field sales teams. Save time, cut admin, and close more deals with less effort.
- Suma Wealth — SUMA is a revolutionary financial wellness company with the mission to engage, educate, and empower the Latinx community via a holistic approach of Digital Media, Experiences, and FinTech. By creating culturally relevant content, virtual experiences, and providing financial tools that demystify and reimagine financial wellness throughentertainment, we aim to become the trusted source to help Latinos own their economic power, overcome financial challenges, and better prepare for a more prosperous future.
- Journey Live — Journey is shifting the way modern companies prioritize mental health. Our proactive, inclusive tools engage every employee, every day.
Flying Kiwi Angels ? Helping Kiwi Startups
Show more...Investment focus
- Industry: Software, Medical Device, Information Technology
- Stage:Seed, Angel, Pre-Seed
- Geography: New Zealand, United States
Investor stats
- Total investments: 21
- Round size: Seed $334k–$4.3M; Angel $592k–$918k; Pre-Seed $473k–$1.3M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- PAM NZ —
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
- Kai's Education — Kai's Education is an innovative force in the EdTech sector, pioneering the integration of coding, STEM, and robotics into engaging learning experiences for children. Based in Auckland, New Zealand, our mission is to ignite young minds through our award-winning educational products, including the all-in-one STEAM toolbox, Kai's Clan, andthe hybrid robot, KaiBot.Our flagship product, Kai's Clan, breaks new ground by allowing children aged seven to fifteen to learn to code with state-of-the-art technologies such as AR, VR, AI, IoT, Tinkercad, and Minecraft. KaiBot, designed for hands-on learning, uses screen-free coding cards to instill the fundamentals of coding, providing immediate feedback to enhance learning.Complemented by the Kainundrum Lite app, Kai's Education facilitates a seamless transition from tactile to advanced text-based coding, nurturing problem-solving skills and creativity. Recipient of the Smart AI Toy Award and the Common Sense Top Pick for Learning Award, Kai's Education is dedicated to equipping the next generation with the skills for tomorrow's challenges. We're not just teaching coding; we're inspiring creators.
Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.
Show more...Investment focus
- Industry: Software, SaaS, Health Care
- Stage:Seed, Angel, Pre-Seed
- Geography: Australia, United States
Investor stats
- Total investments: 95
- Round size: Seed $120k–$1.3M; Angel $130k–$890k; Pre-Seed $337k–$1.5M
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- Keeyu — keeyu. is a B2B SaaS platform that continuously monitors e-commerce transactions from payment to delivery. Should any issue emerge, our system immediately notifies the customer service team, enabling proactive issue resolution before it impacts the customer, saving them from opening a support ticket. The result is an enhanced post-purchaseexperience, ensuring sales retention and reducing customer complaints.Founded in 2023, the company is headquartered in Sydney, Australia, and is dedicated to empowering businesses to deliver exceptional post-purchase experiences.
- ExtrasJar — Swap health insurance premiums for balanced investments and get access to your funds when using health services.
- Mary Technology — Generate detailed chronologies from documents in minutes with Mary Technology. Achieve 90%+ time reduction and ensure 99%+ accuracy. Try for free.
Melbourne Angels was formed in Melbourne, Australia in early 2007. Melbourne Angels is the leading group of private investors in Victoria who actively invest in early stage and growth technology companies.The group has a strong and experienced core of members that generate deal flow, are experienced in evaluation of business propositions and actas mentors for the other members and the entrepreneurs. The members vary in age, gender, ethnicity, profession and type of experience. All members have experience of success at being entrepreneurial.This award winning group is consistently one of the most active startup investors in the country.
Show more...Investment focus
- Industry: Biotechnology, Information Technology, Energy
- Stage:Angel, Seed
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 45
- Round size: Seed $34k–$1.3M; Angel $219k–$918k
- Lead/follow: 49% lead, 51% follow
Portfolio highlights
- Emanda — Emanda App helps business advisory firms and companies determine business value, auto-generate data rooms, set goals, and track progress daily via AI-driven tools.
- Auric Essentials — Auric - The Power of Scent. Revolutionise your well-being with Auric. Discover our state-of-the-art AI-powered AromaSphere diffuser and app, designed to personalise your aromatherapy experience.
- Bitwise Agronomy — Bitwise Agronomy uses AI to analyze crop video footage and provide growers with insights into crop health, growth, and yield potential.
Formed in late 2006, the Brisbane Angels Pty Ltd is a large group of private investors who actively invest in early stage technology companies, usually in South East Queensland, Australia. The members are typically active or semi-retired former senior business executives, who apart from financial input can provide much needed value adding toinvestee companies through hands-on management experience and high level business networks.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Angel
- Geography: Australia, United States, New Zealand
Investor stats
- Total investments: 63
- Round size: Seed $120k–$1.5M; Angel $337k–$629k; Pre-Seed $200k–$1.4M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Giftbee — Giftbee is a B2B gifting marketplace with smart, eco-friendly solutions that enhance value and experience.
- Indi — indi is an assistant for your child's care journey; supporting advocacy, mental health & uniting the village of care.
- Ovum — Meet Ovum, the intelligent health journal mobile app designed for womankind.
IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Therapeutics
- Stage:Seed, Series A
- Geography: United Kingdom, United States, Australia
Investor stats
- Total investments: 194
- Round size: Seed $393k–$7.6M; Series A $2M–$23M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — raised $125M in 2014
Portfolio highlights
- Eight19 — Eight19, located in Cambridge, UK, develops and manufactures plastic photovoltaics for energy harvesting, for the internet of things and for off-grid applications. Through the innovative use of industry-standard, high-volume, roll-to-roll processes and solution-based organic photoactive materials, the company has a highly cost-effective route forscaling-up its technology to supply the largest markets. Eight19 is currently producing modules on a small scale for commercial partners with applications in indoor energy harvesting for wireless sensor and controllers, signage and display, and outdoor power for portable electronics. Our plastic PV modules benefit from flexibility, thinness, light-weight and robustness.
- Slamcore — Positioning, mapping and perception | State-of-the-art visual SLAM turns sensor data into actionable, spatial understanding for your vehicles.
- AudioScenic — THE NEW DIMENSION IN SOUND
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Booster is an investment manager, superannuation and default KiwiSaver scheme provider. We offer ethical, New Zealand and specialist investment options.
Show more...Investment focus
- Industry: Robotics, Biotechnology, Medical Device
- Stage:Seed, Venture - Series Unknown
- Geography: New Zealand, United States
Investor stats
- Total investments: 13
- Round size: Seed $473k–$4.3M; Venture - Series Unknown $158k–$6.1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
- Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
- Wych Limited — Wych an open banking powered digital financial advisor with a focus on personal financial automation.
Significant Ventures is an early-stage venture capital fund backing transformative technologies and the ambitious founders behind them.Founded by the Hindmarsh family, Significant Ventures invests in deep tech, applied science and research-driven innovation emerging from Australia’s leading universities and research institutions. The fundcombines capital with active, hands-on support—helping early-stage companies shape their strategy, attract talent, and access follow-on funding.With a network of expert operators, advisors and institutional partners, Significant Ventures focuses on turning high-potential ideas into globally scalable businesses. The team works closely with founders across sectors including life sciences, climate tech, AI, education and advanced manufacturing.Driven by a commitment to impact, collaboration and long-term value creation, Significant Ventures exists to build the next generation of high-growth companies that will lead Australia’s innovation economy
Show more...Investment focus
- Industry: Manufacturing, Software, Health Care
- Stage:Seed, Series A
- Geography: Australia
Investor stats
- Total investments: 26
- Round size: Seed $67k–$4.6M; Series A $4.5M–$8.2M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Earthodic — Earthodic is an Australian materials science company creating functional biobased coatings. Paperbarc by Earthodic is a biobased water-resistant coating for pulped or paper products. It has better water-resistance than wax coatings, more sustainable and circular than plastic coatings. Repulpable. Re
- Hearables 3D — Scale your custom-fit volumes and solve dental lab technician shortage with AI and automation solutions.
- Visionary Machines — Superior perception for next-generation autonomy
GD1 is a Venture Capital firm that invests with high conviction in exciting technology companies originating from New Zealand. Our team is passionate about creating and growing global businesses, and our goal is to transform NZ made into the next generation of globally disruptive tech solutions.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Series A, Pre-Seed
- Geography: New Zealand, United States, China
Investor stats
- Total investments: 58
- Round size: Seed $600k–$7.3M; Pre-Seed $860k–$2.3M; Series A $1.8M–$16M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- Vessev — Vessev is a maritime trasportantion company that offers hydrofoiling electric vessels for travelling through water.
- VXT — Automate, integrate, and accelerate. Get more from your phone calls for less. VXT Call is a simple, mobile and powerful system.
- Caruso — AI-native fund administration for private markets. Trusted by 900+ real estate, private credit, and private equity funds to save time, impress investors, and grow AUM.
Nuance Capital is a venture capital fund.
Show more...Investment focus
- Industry: Software, Manufacturing, Medical Device
- Stage:Seed, Series A, Convertible Note
- Geography: New Zealand, United States
Investor stats
- Total investments: 13
- Round size: Seed $1.7M–$6.4M; Series A $7.3M–$10M; Convertible Note $3M–$10M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Hectre — Award winning, simple to use orchard apps for performance and cost management optimization.
- Wellumio — Wellumio is a medical technology company redefining the boundaries of clinical imaging. We’re fusing technology, design innovation, and medical expertise to create new diagnostic pathways that support the timely delivery of urgent stroke care.
- Quantifi Photonics — Quantifi Photonics is a critical supplier of photonics test and measurement instruments to the world's leading photonics manufacturers, universities and research organizations.
B2venture is a venture capital firm focused on early-stage investments in digital and industrial technology companies. B2venture invests EUR 100m+ per year in high-growth companies with ticket sizes from EUR 0.25m to 3.5m.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Seed, Series B
- Geography: Germany, Switzerland, United Kingdom
Investor stats
- Total investments: 235
- Round size: Seed $1.3M–$9M; Series A $4M–$22M; Series B $8M–$52M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — raised $135M in 2021
Portfolio highlights
- Kiin Bio — Drug discovery is a system problem, where every inefficiency amplifies the next. We have the solution.
- Kubermatic — Easily manage multiple Kubernetes clusters with the automation power of the Kubermatic platform. Scale your business with reliability.
- Calvin Risk — We help companies manage the risks of their AI algorithms!
FundWA is a Western Australian venture capital fund that invests in technology-enabled innovative businesses in Western Australia.
Show more...Investment focus
- Industry: Medical, Health Care, Manufacturing
- Stage:Seed, Series A
- Geography: Australia
Investor stats
- Total investments: 12
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Enzide — Plastic without Pollution: What if there was a way to make plastic harmless and go away when it's no longer needed? With Australia's best scientists we’ve developed super enzyme technology that makes this possible.
- personr — Single source of truth for AML compliance
- Hola Health — 24 hour online doctors & GP consults via telehealth appointments in 15 minutes. Get instant scripts online, medical certificate online anywhere in Australia.
Sirius Capital is a venture capital firm in China that invests in technology companies.
Show more...Investment focus
- Industry: Artificial Intelligence, Robotics, Video
- Stage:Series A, Seed, Angel
- Geography: China, Australia
Investor stats
- Total investments: 10
- Round size: Seed $1.4M–$4.6M; Series A $7M–$50M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Vantari VR — Virtual Reality for Healthcare
- Zenbot — Zenbot is a high-growth startup specializing in embodied intelligence infrastructure.
- Kuanfen Technology Realcome — Kuanfen Technology Realcome is a brand of AI virtual bloggers that focuses on the use of various AI technologies.
Anova Capital focus on investment in education, big health and new consumption.
Show more...Investment focus
- Industry: Education, Rental, Travel
- Stage:Series A, Seed
- Geography: China, Australia
Investor stats
- Total investments: 4
- Round size: Seed $1.4M–$4.6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Qukoucai — Qukoucai is an online interactive learning platform for children and children. It focuses on providing customized online personal eloquence courses for 4-12 years old children. It includes a complete closed-loop product of teaching, practice, evaluation and display, and is committed to improving children's eloquence. ability.
- Vantari VR — Virtual Reality for Healthcare
- Woody Library — Woody Library is the first subscription-based book sharing and rental platform in China. In the cabin, you can spend the least amount of money, read the most books, and never again, the book that bought the hand has turned over a few pages and found that it has no long-term collection value.
Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Debt Financing
- Geography: United Kingdom, Australia, United States
Investor stats
- Total investments: 238
- Round size: Seed $360k–$3.3M; Debt Financing $18k–$4.1M
- Lead/follow: 60% lead, 40% follow
- Last fund: May invest from a new fund soon — raised $25M in 2018
Portfolio highlights
- Forth — Forth are a group of clinical and digital experts who are passionate about healthcare. They’re part of a new breed of digital healthcare companies who are transforming people’s relationship with their health by using technology to give them more information and help them gain greater control.
- Design and Supply — Design and Supply provides products and services primarily for the construction industry, offering Jansen-certified products and British SBD solutions. The company manufactures and supplies items, including steel doors. Additionally, Design and Supply caters to design enthusiasts by offering artwork, fine furniture, antiques, and decor.
- Reacta Healthcare — Reacta Healthcare develops diagnostic solutions and challenge meals for food allergy testing and clinical research.
Co:Act is an investment partnership of experienced venture investors with a network of founders.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Series A, Seed, Series B
- Geography: Australia, New Zealand
Investor stats
- Total investments: 12
- Round size: Series A $4.4M–$14M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Veyor — The leading live scheduling app for the built environment, helping dispersed teams and their suppliers plan, manage and track daily activity on an easy to use mobile and desktop platform.
- OneReg — OneReg designs and develops software solutions to manage vital documents and regulatory compliance.
- EatClub — EatClub shows you nearby restaurants, with spare tables, offering last minute deals. Receive up to 50% off your bill (including drinks!)
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Discover the UK's leading SEIS Fund, offering tax-efficient investments in innovative startups. Join thousands of savvy investors and raise capital for your business with SFC Capital.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Pre-Seed, Seed
- Geography: United Kingdom, United States, Canada
Investor stats
- Total investments: 489
- Round size: Seed $127k–$2M; Pre-Seed $164k–$839k
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — raised $1.9M in 2019
Portfolio highlights
- Neubond — Neubond develops wearable devices for stroke mobility rehabilitation. These devices provide autonomous assistance and therapy during daily activities, integrating rehabilitation into the patient's daily life regardless of their motor capabilities. Neubond's solutions are designed to be intuitive and effective, aiming to improve thequality of life for individuals undergoing rehabilitation.
- Sages — Biodegradeable, non-polluting, low-impact and vibrant dyes extracted from food waste.
- Traknova — Traknova provides an AI-powered fleet management platform that helps companies track, manage, and protect vehicles and mobile assets. The platform offers real-time GPS tracking, live monitoring, and telematics data to give operators constant visibility over fleet movements and status. Users can access an intuitive dashboard with historical tripinformation, engine status, and alerts for events such as geofence breaches or unauthorized use. Traknova also supports integrated hardware, including tracking devices and online cameras, to strengthen asset security and streamline recovery when issues arise. The system is designed for fleets across industries, such as service businesses and vehicle rental operators, that need clearer scheduling, better time management, and improved operational control. By consolidating these tools into one platform, Traknova enables data-led fleet planning and day-to-day decision-making.
Investing in scalable science and deep tech start-ups in Aotearoa NZ. We operate venture capital funds that invest in science and deep tech through a hands-on, active approach.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Robotics
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: New Zealand, United States
Investor stats
- Total investments: 13
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Liquium —
- Inhibit Coatings — Inhibit Coatings is a New Zealand based company developing novel antimicrobial and antifouling coatings.
- Ampersand Technologies —
The Global Health Investment Fund (GHIF) is a $108 million social impact investment fund designed to provide financing to advance the development of drugs, vaccines, diagnostics and other interventions against diseases that disproportionately burden low- and middle-income countries. GHIF supports late-stage innovations for public health challengessuch as malaria, pre-eclampsia, cholera, HIV and river blindness, with an emphasis on infectious diseases and maternal/infant health issues that cause significant morbidity and mortality in resource-limited settings. GHIF may also make investments that improve or expand access to existing products—such as developing pediatric formulations of approved therapeutics or improving the stability of widely-used global health vaccines.As an investment fund with a limited time-horizon, GHIF seeks opportunities that have a high probability of successful commercialization within two or three years. Products with “dual market” potential are of greatest interest; i.e., those that will have a clear impact on public health in developing countries but also have value in high-income countries. High-volume / low-margin products, such as essential vaccines, are also of significant interest.GHIF employs a range of investment structures including mezzanine debt, convertible debt, preferred equity and project financing with an average investment target of approximately $10 million per project. Each GHIF project must advance the Fund’s social impact objectives and demonstrate the ability to achieve commercial success.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series B, Series C
- Geography: United States, India, Austria
Investor stats
- Total investments: 18
- Round size: Series B $7.5M–$18M; Series C $4.5M–$14M
- Lead/follow: 39% lead, 61% follow
- Last fund: May invest from a new fund soon — raised $108M in 2012
Portfolio highlights
- Monod Bio — Monod Bio l Simple. Powerful. Biosensors for Medicine & Biotech.
- CXL Ophthalmics — CXLO is developing a minimally invasive treatment for an ectatic corneal disease that can bring early intervention to millions of patients globally.
- Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.
Allan Moss acts an adviser to Anchorage’s Investment Committee. Currently Principal of Allan Moss Investments, a private investment company, Allan retired from the role of Managing Director and Chief Executive Officer of Macquarie Group in May 2008. He was with Macquarie Group for 31 years and served as CEO from 1993 to his retirement in2008. He was also a non- executive director of CSR Ltd from 1996 to 2001.Allan graduated from Sydney University in Arts with a major in Economics and in Laws with Honours. He is also a graduate of Harvard University with a Masters Degree in Business Administration with High Distinction. Allan has received numerous industry awards and recognitions. He was twice named by Barron’s Magazine as one of the 30 most respected CEOs in the world (2006, 2007). He was appointed an Officer of the Order of Australia in 2005.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Series A, Seed
- Geography: Australia, United States, The Netherlands
Investor stats
- Total investments: 9
- Round size: Series A $2.4M–$8.8M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Skykraft — Skykraft is an Australian space services firm that specializes in smallsat constellation design, production, and operation.
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Invert Robotics — Invert Robotics develops robotic NDT inspection technologies for the maintenance of industrial equipment in the food and beverage, pharmaceutical, and oil and gas industries. Invert Robotics highly skilled team of engineers have developed a world leading modular inspection platform suitable for use across a range of industries and applications.
Super-seeded by new entry: Flying Kiwi Angels
Show more...Investment focus
- Industry: SaaS, 3D Technology, Medical Device
- Stage:Seed
- Geography: New Zealand
Investor stats
- Total investments: 2
- Round size: Seed $5M–$5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Formus — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.
Show more...Investment focus
- Industry: Software, Financial Services, FinTech
- Stage:Convertible Note, Series B
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 78
- Round size: Series B $7M–$26M; Convertible Note $1.7M–$17M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — raised $54M in 2022
Portfolio highlights
- Send Payments — Seamless cross-border payments for people, businesses and enterprises. Make fast, secure and reliable payments in 100+ currencies to over 170 countries.
- Firmus Technologies —
- Iondrive — Iondrive is an exploration company that provides metals. They offer products that include gold, silver, copper, and other metals. They provide services for industrial use.
Punakaiki Fund Limited makes long-term investments into high-growth, revenue-generating New Zealand companies. The company holds 20 investments, $32.3 million in assets, and is raising money in December 2017 for further investment.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Series A
- Geography: New Zealand, United States
Investor stats
- Total investments: 42
- Round size: Seed $355k–$5M; Series A $1.5M–$12M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Hectre — Award winning, simple to use orchard apps for performance and cost management optimization.
- Quantifi Photonics — Quantifi Photonics is a critical supplier of photonics test and measurement instruments to the world's leading photonics manufacturers, universities and research organizations.
- Sea-Flux Vessel Management Software — Sea-Flu is a cloud-based platform designed to streamline and digitize maritime operations for commercial vessels.
South Australian Venture Capital Fund - helping build dynamic and innovative South Australian startups / scaleups and accelerate their growth to a national and global scale.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Internet of Things
- Stage:Seed, Series B, Series A
- Geography: Australia
Investor stats
- Total investments: 13
- Round size: Seed $1M–$12M; Series A $2.4M–$20M; Series B $13M–$24M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Seonix Bio — Seonix Bio is dedicated to helping health professionals, individuals and researchers understand glaucoma risk using genetics.
- Pearler.AI — Pearler gives your team super powers to respond fast to RFP, RFI, RFQ, Security, Cyber, Risk & Grant Questionnaires.
Left Lane Capital is a venture capital and seed-growth equity firm that invests in high-growth internet and consumer technology businesses that are fundamental to the human condition and spirit – where customers maintain a long-term relationship with the product, platform, or service.
Show more...Investment focus
- Industry: FinTech, Financial Services, Software
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Canada
Investor stats
- Total investments: 155
- Round size: Seed $2.5M–$20M; Series A $9M–$46M; Series B $20M–$100M
- Lead/follow: 61% lead, 39% follow
- Last fund: Likely still investing — raised $1.4B in 2022
Portfolio highlights
- Lexroom.ai — Lexroom.ai allows lawyers to complete hours of legal research in seconds.Legal professionals spend up to 50% of their time in repetitive, low value-adding tasks. That’s why we’re building Lexroom.ai, a product that allows lawyers to complete hours of research in seconds, so they can focus on what really matters.Lexroom.ai perfectly integrateswith lawyers' daily workflow and enables them to speed up time-consuming legal research tasks while increasing output quality, so that they can focus more on value-adding activities.Lexroom.ai is building a bridge between advanced artificial intelligence technologies and legal professionals, through a product specifically tailored to their needs.
- Wayflyer — Wayflyer offers growth financing to eCommerce companies like yours. Sign up, connect your store and analytics, and receive funding offer today.
- Talkiatry — Exceptional psychiatrists, flexible treatment options, and in-network psychiatric care - learn more about Talkiatry and our approach to mental health care.
Bridgewest Ventures is a venture capital company that invests in start-ups commercialized on a global scale.
Show more...Investment focus
- Industry: Manufacturing, Medical Device, Eyewear
- Stage:Seed
- Geography: New Zealand
Investor stats
- Total investments: 3
- Round size: Seed $2.5M–$2.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Luminoma — Luminoma is a medical device manufacturer that offers LumAssure, a device that indicates whether a skin lesion is malignant or benign.
- TheiaNova — TheiaNova provides nonsurgical therapies to patients with vision impairment due to ecstatic vision disorders. A patient suffering from keratoconus will undergo therapeutic remodeling of the cornea with the company's therapy, allowing healthcare professionals to focus on correcting vision impairments with glasses and corrective lenses orhalting progression of the disease with corneal crosslinking.
- Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Renew Pharmaceuticals is an healthcare company.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B
- Geography: Australia
Investor stats
- Total investments: 3
- Round size: Series A $5.6M–$6M
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
Clare Ventures is a growth-stage venture capital fund. Founded, funded, and focused entirely by and for women with a clear goal to help reshape the entrepreneurial landscape and generate meaningful returns, financially and socially, Clare Ventures helps female founders to create lasting impact.
Show more...Investment focus
- Industry: Health Care, Medical Device
- Stage:Series A
- Geography: Australia
Investor stats
- Total investments: 2
- Round size: Series A $1.2M–$4.7M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Oli — Baymatob is an AI-guided solution to improve health outcomes for mothers and their babies.
Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Manufacturing
- Stage:Series A, Seed
- Geography: Australia, United States, United Kingdom
Investor stats
- Total investments: 57
- Round size: Seed $381k–$4.2M; Series A $1.3M–$16M
- Lead/follow: 12% lead, 88% follow
- Last fund: May invest from a new fund soon — raised $14M in 2017
Portfolio highlights
- BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
- Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
- Morse Micro — Morse Micro is a fast-growing wireless integrated circuit solutions company that is reinventing Wi-Fi for the Internet of Things (IoT). The company was founded by Wi-Fi pioneers and innovators, Michael De Nil and Andrew Terry, joined by the original Wi-Fi inventor Prof. Neil Weste and wireless industry veterans, whose teams designed Wi-Fi chipsinto billions of smartphones. Headquartered in Australia with offices in China and the U.S., Morse Micro’s strong and diverse system team, portfolio of IP and patents, enables Wi-Fi HaLow connectivity across the complete IoT ecosystem, from surveillance systems and access control to industrial automation and mobile devices, allowing connected devices to reach farther. www.morsemicro.com
The CP Ventures Fund invests in early-stage technology companies that are highly scalable, at the forefront of breakthrough technologies, and driven by the fourth industrial revolution.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Seed, Pre-Seed
- Geography: Australia, United States, India
Investor stats
- Total investments: 58
- Round size: Seed $417k–$3.9M; Pre-Seed $350k–$900k
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- LeadStory — Watch breaking news from around the world and stay up to date with current events. Follow topics that matter to you from providers you can trust. See whats happening nearby or in places you care about.
- Greenfly — Greenfly's short-form media orchestration software platform captures, collects, organizes & distributes videos & photos to drive fan engagement and boost revenue for sports and entertainment organizations.
- Skylark Labs — Skylark Labs develops continuously evolving and customizable threat detection systems for enhanced physical security. Our clients (CCTV or Drone companies) can customize our proprietary AI solutions at the time of deployment or continuously evolve them if needed after deployment making them preferable to other comparable market solutions.
Quayside Holdings is the investment arm of the Bay of Plenty Regional Council which responsibly manages the listed assets, property, equities and private equity investments.
Show more...Investment focus
- Industry: Sensor, FinTech, Hardware
- Stage:Seed, Series B
- Geography: New Zealand
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- TradeWindow — TradeWindow provides the tools and support for exporters, importers, freight forwarders, and customs brokers to begin the journey to digital transformation.
- WNT Ventures — New Zealand's Venture Capital Deep Tech Investor. Investing in Deeptech founders from Aotearoa to build local companies and help them go global
Investing in the deep science and technology that can propel humanity towards a radically better future.
Show more...Investment focus
- Industry: Biotechnology, Software, Artificial Intelligence
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 250
- Round size: Seed $1M–$11M; Series A $6.2M–$50M; Series B $8M–$110M
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- Scopely — Scopely is a global interactive entertainment and mobile-first games company, home to many top-grossing, award-winning franchises including “Star Trek™ Fleet Command,” “MARVEL Strike Force,” “Scrabble® GO,” “WWE Champions” and “Yahtzee® With Buddies,” among others. Scopely creates, publishes and live-operates immersive games that empower adirected-by-consumer™ experience. Founded in 2011, Scopely is fueled by a world-class team and a proprietary technology platform Playgami that supports one of the most diversified portfolios in the mobile games industry. Recognized multiple times as one of Fast Company’s “World’s Most Innovative Companies,” Scopely is a multi-billion-dollar business due to its ability to create long-lasting game experiences that players enjoy for years. Scopely has global operations across 17 markets (Asia-Pacific - Bangalore, Seoul, Shanghai, Singapore, Tokyo; EMEA - Barcelona, Dublin, Helsinki, Kyiv, London, Seville, Tel Aviv; North America - Boston, Boulder, Culver City, Mountain View, San Francisco), with additional game studio partners across four continents. For more information, visit www.scopely.com.
- Synthace — The Synthace Experiment Platform lets you design powerful experiments, run them in your lab, & gather automatically structured datasets. No code necessary.
- Amper Music — Amper is an AI music composition company that develops tools for content creators of all kinds. Learn about our new enterprise platform, Score, as well as our creator API.
Ramsay Health Care provides health care services to public and private patients. Its health care services comprise day surgery procedures and complex surgeries, as well as psychiatric care and rehabilitation services. It operates approximately 235 hospitals and day surgery facilities with approximately 25,000 beds in Australia, the United Kingdom,France, Indonesia, Malaysia, Maldives, and Italy. Paul Ramsay founded Ramsay Health Care in 1964. It has its headquarters in Sydney in Australia.
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Series A
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Harrison.ai — Harrison.ai is a clinician-led healthcare AI company using deep learning to improve the odds of IVF success for thousands of patients. The company leverages deep learning to solve the biggest challenges in healthcare and seeks to improve patient outcomes. It empowers physicians and healthcare providers with customized AI-enabled tools thatintegrate into existing clinical workflows which ultimately lead to improved patient outcomes.Harrison.ai uses the deskside DGX Station for experimentation, research, and development. The company uniquely combines exceptional deep learning expertise with clinical experience to develop and deploy healthcare AI solutions. Harrison.ai’s IVY deep learning model analyzes the full five-day video feed from an embryo scope, helping it surpass the performance of AI tools that provide insights based on still images.Harrison.ai's mission is to continuously innovate and commercialize more efficient and more affordable healthcare products and services to healthcare providers and patients.Harrison.ai was founded in 2018 and is headquartered in Barongarook, Victoria, Australia.
OneVentures is a later-stage venture capital firm focused on scaling Technology and Healthcare companies through growth equity and credit. The firm's role extends far beyond investment, as the firm actively guides companies toward achieving their next critical milestones. By leveraging decades of global experience and operational expertise,OneVentures accelerates growth and helps shape the future of its portfolio companies.A global growth focus drives their investment selection, with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Debt Financing
- Geography: Australia, United States, Israel
Investor stats
- Total investments: 77
- Round size: Series A $1.5M–$20M; Debt Financing $1M–$6.7M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely still investing — raised $145M in 2022
Portfolio highlights
- Vaxxas — Vaxxas develops and commercializes needle-free vaccine delivery system. Vaxxas was incorporated in 2011 and is based in Brisbane, Australia.
- Kira Biotech — Kira Biotech is an emerging Australian biotechnology company developing novel immunomodulatory compounds for the treatment of immune system disorders. Its lead candidate, KB312, is a first-in-class, selective, immune-cell depleting monoclonal antibody which targets activated immune cells and aims to restore homeostasis through induction of immunetolerance. Kira Biotech has attracted venture capital funding and is progressing KB312 through preclinical development and phase 1 clinical trials with a team of drug development experts led by well-known US-based rheumatologist and immunologist, Dr Dan Baker.
- Vertero — Axial Therapeutics is a biotechnology company fundamentally changing the treatment of neurological diseases and disorders by harnessing groundbreaking science in the microbiome-gut-brain axis.
HealthCare Ventures is a leading life science venture capital firm investing in pre-clinical or early clinical stage, focused companies with potential to transform patient care.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series B, Series A, Series C
- Geography: United States, Australia, United Kingdom
Investor stats
- Total investments: 103
- Round size: Series A $4.4M–$37M; Series B $10M–$50M; Series C $15M–$44M
- Lead/follow: 17% lead, 83% follow
- Last fund: May invest from a new fund soon — raised $250M in 2010
Portfolio highlights
- Colorescience — Know Better Skin with Colorescience. From mineral sunscreen to clinical skincare products, achieve a clear, even complexion and protect your skin from the damaging effects of the sun and environmental aggressors such as pollution. Shop Now!
- Leap Therapeutics — Leap Therapeutics, Inc., a clinical-stage biopharmaceutical company, is engaged in acquiring and developing novel therapeutics. The company focus is to identify translational-stage molecules in the areas of cell signaling and immuno-oncology.
- Proteostasis Therapeutics — Proteostasis Therapeutics is discovering and developing novel small molecule therapeutics designed to control the body's protein homeostasis, or Proteostasis Network. The Proteostasis Network maintains the body's natural balance of proteins to protect us from numerous diseases. These novel therapies, or Proteostasis Regulators, aredesigned to treat multiple genetic and degenerative disorders associated with deficiencies of the Proteostasis Network, such as emphysema, type II diabetes, Alzheimer's Disease and Huntington's Disease.
A fund focused on delivering long term capital growth whilst increasing the wellbeing of Australians by investing in the future healthcare needs of Australians.
Show more...Investment focus
- Industry: Health Care, Medical Device
- Stage:Series A
- Geography: Australia
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Oli — Baymatob is an AI-guided solution to improve health outcomes for mothers and their babies.
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device Investors in Oceania investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 investors investing in Oceania Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!